On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
data monitoring committee
.
Show all posts
Showing posts with label
data monitoring committee
.
Show all posts
Sunday, March 31, 2024
What's New in FDA's Draft Guidance "Use of Data Monitoring Committees in Clinical Trials"?
›
In early 2024, the FDA unveiled its latest drug guidance for the industry titled " Use of Data Monitoring Committees in Clinical Trials...
Thursday, December 01, 2022
Sample size re-estimation or sample size increase?
›
Recently, a press release from a biotech company caught my eye. This seems to be an example of the adaptive design with sample size re-esti...
1 comment:
›
Home
View web version
